Herein, promising therapeutic approaches were aroused, such as the TNFα/TNFR1 axis blockage to prevent NAFLD progression, anti-TGF-β therapy to alleviate liver fibrosis or neutralization of IFNγ activity to revert both liver inflammation and injury. Here, IFNG is linked to Hepatic fibrosis.